Cephalometric evaluation of rapid and slow maxillary expansion in patients with BCLP: Secondary data analysis from a randomized clinical trial

• Published in: The Angle orthodontist Vol. 89; no. 4; pp. 583 - 589
• Main Authors: Gregório, Leonardo, de Medeiros Alves, Arthur César, de Almeida, Araci Malagodi, Naveda, Rodrigo, Janson, Guilherme, Garib, Daniela
• Format: Journal Article
• Language: English
• Published: United States Edward H. Angle Society of Orthodontists 01-07-2019
• Subjects: Cephalometry; Child; Cleft Lip; Cleft Palate; Data Analysis; Dentistry; Female; Humans; Male; Maxilla; Original; Palatal Expansion Technique; Cephalometry; Cleft lip and palate; Palatal expansion technique
• ISSN: 0003-3219; 1945-7103
• DOI: 10.2319/081018-589.1

To compare the dentoskeletal effects of rapid (RME) and slow (SME) maxillary expansion in patients with bilateral complete cleft lip and palate (BCLP).
This was a secondary analysis of a previous randomized controlled trial (RCT). Forty-six patients (34 male, 12 female) with BCLP and posterior crossbite (mean age of 9.2 years) were randomly assigned to two study groups. Group RME comprised subjects treated with Haas/Hyrax expander. Group SME included patients treated with quad-helix appliance. Cone-beam computed tomography (CBCT) was performed before expansion (T1) and after appliance removal at the end of a 6-month retention period (T2) for a previous RCT that compared the transverse skeletal effects of RME and SME. CBCT-derived cephalometric images were generated and cephalometric analysis was performed using Dolphin Imaging Software (Chatsworth, Calif). Intergroup comparisons were performed using
tests (
< .05).
Baseline forms were similar between groups. No significant differences between RME and SME groups were found.
Rapid and slow maxillary expansion produced similar sagittal and vertical changes in patients with BCLP. Both Haas/Hyrax and quad-helix appliances can be used in patients with vertical facial pattern. Clinical relevance: RME and SME can be equally indicated in the treatment of maxillary arch constriction in patients with BCLP.